Subsequently, we explored other tumor cell lines harboring gain‐of‐function type mutations in tyrosine kinases, and found the expression of CEACAM1 mRNA and protein in a human medullary thyroid carcinoma (MTC) cell line, TT. The gene discussed is CEACAM1; the disease is medullary thyroid gland carcinoma.